A citation-based method for searching scientific literature

Charlotte K Boughton, Roman Hovorka. Diabetologia 2021
Times Cited: 21







List of co-cited articles
134 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
223
42

'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
Mark A Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee, Michael A Weiss. Diabetologia 2021
13
61


A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
Marc D Breton, Lauren G Kanapka, Roy W Beck, Laya Ekhlaspour, Gregory P Forlenza, Eda Cengiz, Melissa Schoelwer, Katrina J Ruedy, Emily Jost, Lori Carria,[...]. N Engl J Med 2020
63
33

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Julio Rosenstock, Harpreet S Bajaj, Andrej Janež, Robert Silver, Kamilla Begtrup, Melissa V Hansen, Ting Jia, Ronald Goldenberg. N Engl J Med 2020
45
28

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.
Inge B Halberg, Karsten Lyby, Karsten Wassermann, Tim Heise, Eric Zijlstra, Leona Plum-Mörschel. Lancet Diabetes Endocrinol 2019
61
23

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
Martin Tauschmann, Hood Thabit, Lia Bally, Janet M Allen, Sara Hartnell, Malgorzata E Wilinska, Yue Ruan, Judy Sibayan, Craig Kollman, Peiyao Cheng,[...]. Lancet 2018
134
23

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
Eleni Bekiari, Konstantinos Kitsios, Hood Thabit, Martin Tauschmann, Eleni Athanasiadou, Thomas Karagiannis, Anna-Bettina Haidich, Roman Hovorka, Apostolos Tsapas. BMJ 2018
164
23

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
612
23

An ingestible self-orienting system for oral delivery of macromolecules.
Alex Abramson, Ester Caffarel-Salvador, Minsoo Khang, David Dellal, David Silverstein, Yuan Gao, Morten Revsgaard Frederiksen, Andreas Vegge, František Hubálek, Jorrit J Water,[...]. Science 2019
107
19

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
19

Review: Glucose-sensitive insulin.
Thomas Hoeg-Jensen. Mol Metab 2021
13
30

Engineering Glucose Responsiveness Into Insulin.
Niels C Kaarsholm, Songnian Lin, Lin Yan, Theresa Kelly, Margaret van Heek, James Mu, Margaret Wu, Ge Dai, Yan Cui, Yonghua Zhu,[...]. Diabetes 2018
35
19

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.
Gregory P Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, Dorothy I Shulman, Timothy S Bailey, Bruce W Bode, Michael A Wood, Bruce A Buckingham, Kevin B Kaiserman, John Shin,[...]. Diabetes Technol Ther 2019
73
19


A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.
Richard M Bergenstal, Revital Nimri, Roy W Beck, Amy Criego, Lori Laffel, Desmond Schatz, Tadej Battelino, Thomas Danne, Stuart A Weinzimer, Judy Sibayan,[...]. Lancet 2021
41
19

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
734
19

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
313
19

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
9
44

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
21
19

A global perspective on the issue of access to insulin.
David Beran, Maria Lazo-Porras, Camille M Mba, Jean Claude Mbanya. Diabetologia 2021
17
17

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
Firas H El-Khatib, Courtney Balliro, Mallory A Hillard, Kendra L Magyar, Laya Ekhlaspour, Manasi Sinha, Debbie Mondesir, Aryan Esmaeili, Celia Hartigan, Michael J Thompson,[...]. Lancet 2017
122
14

Smarter Modeling to Enable a Smarter Insulin.
Simeon I Taylor, Richard D DiMarchi. Diabetes 2020
6
50

How insulin engages its primary binding site on the insulin receptor.
John G Menting, Jonathan Whittaker, Mai B Margetts, Linda J Whittaker, Geoffrey K-W Kong, Brian J Smith, Christopher J Watson, Lenka Záková, Emília Kletvíková, Jiří Jiráček,[...]. Nature 2013
215
14

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
273
14

Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
Martin Tauschmann, Janet M Allen, Katrin Nagl, Maria Fritsch, James Yong, Emily Metcalfe, Dominique Schaeffer, Muriel Fichelle, Ulrike Schierloh, Alena G Thiele,[...]. Diabetes Care 2019
36
14

A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.
Laurel H Messer, Cari Berget, Gregory P Forlenza. Diabetes Technol Ther 2019
25
14

Hybrid closed-loop therapy: Where are we in 2021?
Lalantha Leelarathna, Pratik Choudhary, Emma G Wilmot, Alistair Lumb, Tim Street, Partha Kar, Sze M Ng. Diabetes Obes Metab 2021
14
21

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
803
14

Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
Vasilios Karageorgiou, Theodoros G Papaioannou, Ioannis Bellos, Krystallenia Alexandraki, Nikolaos Tentolouris, Christodoulos Stefanadis, George P Chrousos, Dimitrios Tousoulis. Metabolism 2019
33
14

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.
Stacey M Anderson, Bruce A Buckingham, Marc D Breton, Jessica L Robic, Charlotte L Barnett, Christian A Wakeman, Mary C Oliveri, Sue A Brown, Trang T Ly, Paula K Clinton,[...]. Diabetes Technol Ther 2019
20
15

Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.
Jordan E Pinsker, Lars Müller, Alexandra Constantin, Scott Leas, Michelle Manning, Molly McElwee Malloy, Harsimran Singh, Steph Habif. Diabetes Technol Ther 2021
26
14

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Harpreet S Bajaj, Richard M Bergenstal, Andreas Christoffersen, Melanie J Davies, Amoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A Senior, Robert J Silver, Roberto Trevisan,[...]. Diabetes Care 2021
12
25

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
Ildiko Lingvay, John B Buse, Edward Franek, Melissa V Hansen, Mette M Koefoed, Chantal Mathieu, Jeremy Pettus, Karolina Stachlewska, Julio Rosenstock. Diabetes Care 2021
8
37


A combined risk score enhances prediction of type 1 diabetes among susceptible children.
Lauric A Ferrat, Kendra Vehik, Seth A Sharp, Åke Lernmark, Marian J Rewers, Jin-Xiong She, Anette-G Ziegler, Jorma Toppari, Beena Akolkar, Jeffrey P Krischer,[...]. Nat Med 2020
22
9

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.
Hillary A Keenan, Jennifer K Sun, Jared Levine, Alessandro Doria, Lloyd P Aiello, George Eisenbarth, Susan Bonner-Weir, George L King. Diabetes 2010
322
9


An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Kevan C Herold, Brian N Bundy, S Alice Long, Jeffrey A Bluestone, Linda A DiMeglio, Matthew J Dufort, Stephen E Gitelman, Peter A Gottlieb, Jeffrey P Krischer, Peter S Linsley,[...]. N Engl J Med 2019
215
9

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
Teresa Quattrin, Michael J Haller, Andrea K Steck, Eric I Felner, Yinglei Li, Yichuan Xia, Jocelyn H Leu, Ramineh Zoka, Joseph A Hedrick, Mark R Rigby,[...]. N Engl J Med 2020
30
9

The consequences of hypoglycaemia.
Stephanie A Amiel. Diabetologia 2021
5
40




Red Blood Cells for Glucose-Responsive Insulin Delivery.
Chao Wang, Yanqi Ye, Wujin Sun, Jicheng Yu, Jingqiang Wang, David S Lawrence, John B Buse, Zhen Gu. Adv Mater 2017
81
9

A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision Making.
Sandra A G Visser, Bhargava Kandala, Craig Fancourt, Alexander W Krug, Carolyn R Cho. Clin Pharmacol Ther 2020
7
28

Recent progress in design and preparation of glucose-responsive insulin delivery systems.
Di Shen, Haojie Yu, Li Wang, Amin Khan, Fazal Haq, Xiang Chen, Qiao Huang, Lisong Teng. J Control Release 2020
25
9

Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
Jessica R Castle, Joseph El Youssef, Leah M Wilson, Ravi Reddy, Navid Resalat, Deborah Branigan, Katrina Ramsey, Joseph Leitschuh, Uma Rajhbeharrysingh, Brian Senf,[...]. Diabetes Care 2018
70
9

Development of glucose-responsive 'smart' insulin systems.
Nischay K Rege, Nelson F B Phillips, Michael A Weiss. Curr Opin Endocrinol Diabetes Obes 2017
27
9

Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
Ionut Bebu, Barbara H Braffett, Trevor J Orchard, Gayle M Lorenzi, John M Lachin. Diabetes Care 2019
23
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.